Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04892342
What this trial is testing

Study of ESG401 in Adults With Solid Tumors

Who this might be right for
Neoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more
Shanghai Escugen Biotechnology Co., Ltd 156
Testing effectiveness (Phase 2)UnknownNCT05785728
What this trial is testing

DB-1202 Monotherapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 150
Early research (Phase 1)Study completedNCT04728334
What this trial is testing

Dose Escalation and Expansion Study of AK117

Who this might be right for
Neoplasms Malignant
Akeso 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06770881
What this trial is testing

JSKN033 in Chinese Subjects with Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 430
Testing effectiveness (Phase 2)WithdrawnNCT05145569
What this trial is testing

Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Haider Mahdi
Early research (Phase 1)Study completedNCT04805307
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Who this might be right for
Advanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer
Keymed Biosciences Co.Ltd 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT06125522
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Who this might be right for
Breast Cancer
Pfizer 11
Early research (Phase 1)Looking for participantsNCT06404905
What this trial is testing

Clinical Trial of BT02 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Looking for participantsNCT05551507
What this trial is testing

IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
InxMed (Shanghai) Co., Ltd. 150
Early research (Phase 1)Study completedNCT03666143
What this trial is testing

A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 216
Testing effectiveness (Phase 2)Active Not RecruitingNCT05744427
What this trial is testing

Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 725
Early research (Phase 1)Looking for participantsNCT07032298
What this trial is testing

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD. 30
Not applicableNot Yet RecruitingNCT06764537
What this trial is testing

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

Who this might be right for
Glioblastoma
Central Hospital, Nancy, France 18
Early research (Phase 1)Looking for participantsNCT07376707
What this trial is testing

TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more
Hefei TG ImmunoPharma Co., Ltd. 194
Early research (Phase 1)UnknownNCT04727164
What this trial is testing

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Who this might be right for
Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd. 61
Testing effectiveness (Phase 2)Study completedNCT03752723
What this trial is testing

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

Who this might be right for
Triple Negative Breast Cancer
Genexine, Inc. 84
Early research (Phase 1)Ended earlyNCT06331559
What this trial is testing

Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 13
Testing effectiveness (Phase 2)Study completedNCT04381650
What this trial is testing

TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Takeda 161
Testing effectiveness (Phase 2)Study completedNCT03732274
What this trial is testing

Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
MedPacto, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07508761
What this trial is testing

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Nanjing Immunophage Biotech Co., Ltd 52
Next Page